Tag: rebalance

CUE-401, a first-in-class bispecific molecule designed to induce and expand Tregs in vivo through the co-activity of transforming TGF-β and a modified variant of IL-2

Deer Park, TX, June 20, 2025 (GLOBE NEWSWIRE) -- As the Texas real estate market cools, it’s beginning to rebalance. Inventory is increasing, price growth is slowing, and homes are staying on the market longer, especially those that need updates or are priced too high.

Cardiff, United Kingdom – 18 June 2025 – Draig Therapeutics (“Draig”), a clinical-stage company aiming to transform the treatment of neuropsychiatric diseases, today launches from stealth having raised a total of $140 million (£107 million) in the last nine months. The oversubscribed Series A financing was led by Access Biotechnology, with participation from Canaan Partners, SR One, Sanofi Ventures, Schroders Capital along with seed investors SV Health Investors, which co-founded the company, and ICG.

TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock, Inc. (“BlackRock”) (NYSE: BLK), is announcing that iShares Jantzi Social Index ETF (the “iShares ETF”) is expected to experience higher than normal portfolio turnover as a result of upcoming changes to the evaluation process used to determine the composition of the Morningstar Jantzi Social Index (the “Index”). The iShares ETF seeks to replicate the performance of the Index, net of expenses. The composition of the Index will change as part of its regularly scheduled rebalance on June 20, 2025 (the “Rebalance”). As a result of the Rebalance, the iShares ETF may experience higher than normal transaction costs and is also expected to realize net capital gains. However, the iShares ETF’s total net capital gains income for the year will not be known until its tax year ends on December 15, 2025. The iShares ETF will follow its normal process for determining and distributing capital gains in December 2025.